Prognostic value of the second revision of the international staging system (R2-ISS) in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation

被引：1
|
作者：
Kikuchi, Taku [1 ,2 ]
Tsukada, Nobuhiro [1 ]
Kunisada, Kodai [1 ]
Yogo, Moe [1 ]
Oda, Yuki [1 ]
Sato, Kota [1 ]
Takei, Tomomi [1 ]
Ogura, Mizuki [1 ]
Abe, Yu [1 ]
Suzuki, Kenshi [1 ]
Ishida, Tadao [1 ]
机构：
[1] Japanese Red Cross Med Ctr, Dept Hematol, Tokyo, Japan
[2] Japanese Red Cross Med Ctr, Dept Hematol, 4 Chome-1-22 Hiroo, Tokyo 1508935, Japan
来源：
HEMATOLOGICAL ONCOLOGY | 2024年 / 42卷 / 01期
关键词：
MINIMAL RESIDUAL DISEASE; LENALIDOMIDE MAINTENANCE;
D O I：
10.1002/hon.3248
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [31] Clonal hematopoiesis in patients with multiple myeloma undergoing autologous stem cell transplantation
    Sneha Chitre
    Friedrich Stölzel
    Kirsty Cuthill
    Mathew Streetly
    Charlotte Graham
    Claudia Dill
    Azim Mohamedali
    Alexander Smith
    Johannes Schetelig
    Heidi Altmann
    Martin Bornhäuser
    Ghulam J. Mufti
    Leukemia, 2018, 32 : 2020 - 2024
  • [32] Stratification of patients with multiple myeloma and lymphoma undergoing autologous hematopoietic stem cell transplantation in term of antifungal prophylaxis
    Moghnieh, R.
    Khaldieh, S.
    Awad, L.
    Abdallah, D.
    Droubi, N.
    Youssef, A.
    Mougharbel, A.
    Jisr, T.
    Ibrahiim, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S266 - S266
  • [33] Edentulism and transplant-associated complications in patients with multiple myeloma undergoing autologous hematopoietic stem cell transplantation
    Juan Jose Toro
    Francisca Cecilia Gushiken
    Deanna Schneider
    Shuko Lee
    David Johannes Haile
    Cesar Ovidio Freytes
    Supportive Care in Cancer, 2016, 24 : 3411 - 3415
  • [34] Second Autologous Stem Cell Transplantation in Poor Stem Cell Mobilizers Multiple Myeloma Patients
    Sever, Matjaz
    Sbianchi, Giulia
    Iacobelli, Simona
    van der Werf, Steffie
    Wieslaw, Wiktor-Jedrzejczak
    Blaise, Didier
    Apperley, Jane F.
    Mohty, Mohamad
    Scheid, Christof
    Wilson, Keith
    Russel, Nigel H.
    Kalhs, Peter
    Chevallier, Patrice
    Ringhoffer, Mark
    Kobbe, Guido
    Mayer, Jiri
    Jost, Edgar
    Zudaire, Teresa
    Schiel, Xaver
    Isaksson, Cecilia
    Trneny, Marek
    Schonland, Stefan
    Morris, Curly
    Garderet, Laurent
    Kroeger, Nicolaus
    BLOOD, 2017, 130
  • [35] Staging Systems for Newly Diagnosed Myeloma Patients Undergoing Autologous Hematopoietic Cell Transplantation: The Revised International Staging System Shows the Most Differentiation between Groups
    Scott, Emma C.
    Hari, Parameswaran
    Kumar, Sathish
    Fraser, Raphael
    Davila, Omar
    Shahs, Nina
    Gale, Robert Peter
    Diaz, Miguel Angel
    Agrawal, Vaibhav
    Cornell, Robert F.
    Ganguly, Siddhartha
    Akpek, Gorgun
    Freytes, Cesar
    Hashmi, Shahrukh
    Malek, Ehsan
    Kamble, Rammurti T.
    Lazarus, Hillard
    Solh, Melhem
    Usmani, Saad Z.
    Kanate, Abraham S.
    Saad, Ayman
    Chhabra, Saurabh
    Gergis, Usama
    Cerny, Jan
    Kyle, Robert A.
    Lee, Cindy
    Kindwall-Keller, Tamila
    Assal, Amer
    Hildebrandt, Gerhard C.
    Holmberg, Leona
    Maziarz, Richard T.
    Nishihori, Taiga
    Seo, Sachiko
    Kumar, Shaji
    Mark, Tomer
    D'Souza, Anita
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (12) : 2443 - 2449
  • [36] Impact of revised International Staging System 2 risk stratification on outcomes of patients with multiple myeloma receiving autologous haematopoietic stem cell transplantation
    Alzahrani, Kamal
    Pasvolsky, Oren
    Wang, Zhongya
    Milton, Denai R.
    Tanner, Mark R.
    Bashir, Qaiser
    Srour, Samer
    Saini, Neeraj
    Lin, Paul
    Ramdial, Jeremy
    Nieto, Yago
    Lee, Hans C.
    Patel, Krina K.
    Manasanch, Elisabet E.
    Kebriaei, Partow
    Thomas, Sheeba K.
    Weber, Donna M.
    Orlowski, Robert Z.
    Shpall, Elizabeth J.
    Champlin, Richard
    Qazilbash, Muzaffar H.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1944 - 1952
  • [37] Use of Backup Stem Cells for Stem Cell Boost and Second Transplant in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation
    Liang, Emily C.
    Muffly, Lori S.
    Shiraz, Parveen
    Shizuru, Judith A.
    Johnston, Laura
    Arai, Sally
    Frank, Matthew J.
    Weng, Wen-Kai
    Lowsky, Robert
    Rezvani, Andrew
    Meyer, Everett H.
    Negrin, Robert
    Miklos, David B.
    Sidana, Surbhi
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 405.e1 - 405.e6
  • [38] Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma
    Shuji Ozaki
    Hiroshi Handa
    Takayuki Saitoh
    Hirokazu Murakami
    Mitsuhiro Itagaki
    Hideki Asaoku
    Kenshi Suzuki
    Atsushi Isoda
    Morio Matsumoto
    Morio Sawamura
    Kazutaka Sunami
    Naoki Takezako
    Shotaro Hagiwara
    Yoshiaki Kuroda
    Takaaki Chou
    Eiichi Nagura
    Kazuyuki Shimizu
    Annals of Hematology, 2019, 98 : 1703 - 1711
  • [39] Evaluation of the Revised International Staging System (R-ISS) in Japanese patients with multiple myeloma
    Ozaki, Shuji
    Handa, Hiroshi
    Saitoh, Takayuki
    Murakami, Hirokazu
    Itagaki, Mitsuhiro
    Asaoku, Hideki
    Suzuki, Kenshi
    Isoda, Atsushi
    Matsumoto, Morio
    Sawamura, Morio
    Sunami, Kazutaka
    Takezako, Naoki
    Hagiwara, Shotaro
    Kuroda, Yoshiaki
    Chou, Takaaki
    Nagura, Eiichi
    Shimizu, Kazuyuki
    ANNALS OF HEMATOLOGY, 2019, 98 (07) : 1703 - 1711
  • [40] Prevalence and significance of sarcopenia in multiple myeloma patients undergoing autologous hematopoietic cell transplantation
    Alexis Williams
    Dhiraj Baruah
    Jayshil Patel
    Aniko Szabo
    Saurabh Chhabra
    Binod Dhakal
    Parameswaran Hari
    Siegfried Janz
    Melinda Stolley
    Anita D’Souza
    Bone Marrow Transplantation, 2021, 56 : 225 - 231
12345